On November 15, scientists announced the successful trial of a new medication to help people quit smoking.
Numerous studies have been conducted in Europe over the past year involving around 2,000 smokers using a new drug called varenicline from Pfizer Pharmaceuticals. The results show that this medication helps 22% of participants quit smoking.
Dr. Serena Tonstad, a cardiovascular disease prevention expert at the University of Oslo in Norway, noted that the side effect of this drug is mild nausea, but it is manageable.
Varenicline works entirely differently from nicotine gum, patches, and other medications currently used to aid smoking cessation. It “binds” to nicotine receptors in the brain, which are responsible for nicotine addiction.
T.VY (According to AP)
